Point72 Asset Management
MIRM icon

Point72 Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Point72 Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-346,991
Closed -$34.8M – 4376
2026
Q1 		$32.1M Buy
346,991
+156,353
+82% +$14.7M 0.04% 572
2025
Q4 		$15.1M Sell
190,638
-600,037
-76% -$43.1M 0.02% 1092
2025
Q3 		$58M Buy
790,675
+531,809
+205% +$33.8M 0.1% 235
2025
Q2 		$13.2M Buy
258,866
+26,768
+12% +$1.19M 0.03% 636
2025
Q1 		$10.5M Buy
+232,098
New +$10.9M 0.02% 668
2023
Q3 		– Sell
-601,038
Closed -$15.5M – 2725
2023
Q2 		$15.5M Buy
601,038
+43,600
+8% +$1.16M 0.05% 456
2023
Q1 		$13.4M Buy
557,438
+217,928
+64% +$4.97M 0.04% 464
2022
Q4 		$6.62M Buy
+339,510
New +$6.71M 0.02% 677
2022
Q2 		– Sell
-153,389
Closed -$3.38M – 1540
2022
Q1 		$3.38M Sell
153,389
-161,454
-51% -$3.29M 0.01% 782
2021
Q4 		$5.02M Buy
314,843
+170,443
+118% +$2.65M 0.02% 667
2021
Q3 		$2.88M Buy
144,400
+125,600
+668% +$2.04M 0.01% 747
2021
Q2 		$325K Buy
18,800
+13,800
+276% +$247K ﹤0.01% 889
2021
Q1 		$99K Buy
+5,000
New +$95.7K ﹤0.01% 906
2020
Q3 		– Sell
-97,415
Closed -$1.9M – 1026
2020
Q2 		$1.9M Buy
+97,415
New +$1.63M 0.01% 601

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Asset Management's MIRM Position: Q2 2026 in Review

Point72 Asset Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 346,991 shares — an estimated $34.8M sold.

Point72 Asset Management first reported a position in MIRM in Q2 2020 and held it in 14 quarters. The position peaked at $58M in Q3 2025. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Point72 Asset Management reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 346,991 Mirum Pharmaceuticals shares in Q2 2026, an estimated $34.8M.
  • Point72 Asset Management first reported a position in Mirum Pharmaceuticals in Q2 2020 and held it in 14 quarters.
  • Point72 Asset Management's Mirum Pharmaceuticals position peaked at $58M in Q3 2025.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.